Adair Lab: Brian D. Adair, PhD
Our laboratory at Massachusetts General Hospital focuses on the structure determination of macromolecules, including membrane proteins, employing electron cryomicroscopy.
Safe Care CommitmentGet the latest news on COVID-19, the vaccine and care at Mass General.Learn more
Our laboratory at Massachusetts General Hospital focuses on the structure determination of macromolecules, including membrane proteins, employing electron cryomicroscopy.
Our lab at Massachusetts General Hospital studies study hepatorenal syndrome in order to understand how advanced liver disease (cirrhosis) affects kidney function.
Our lab at Massachusetts General Hospital is working on the structure-function relationship of the integrin receptors, in particular Beta2, AlphavBeta3, and AlphaIIbBeta3 integrins.
The M. Amin Arnaout laboratory at Massachusetts General Hospital researches the molecular basis of human disease to guide development of new and safer therapies, using genetics, genomics, biochemistry, cell biology, structural and computational biology and animal models.
The Jodie L. Babitt Lab at Massachusetts General Hospital is focused on elucidating the molecular and cellular mechanisms involved in iron homeostasis
The Richard Bouley Laboratory at Massachusetts General Hospital is studying the role of vasopressin receptor type 2 in the pathophysiology of diseases associated with water reabsorption dysregulation.
The Sylvie Breton Lab at Massachusetts General Hospital studies the regulation of epithelial cells in the urogenital tract. Our main areas of interest are acute kidney injury, chronic kidney disease, male infertility, cystic fibrosis, and pH homeostasis.
The Brown Lab at Massachusetts General Hospital researches mechanisms and signals that regulate the distribution of important proteins in the kidney, controlling urine concentration and systemic acid base balance.
The Cui Lab at Massachusetts General Hospital interested in improving our understanding of and developing new treatment strategies for hemodialysis access dysfunction.
The Kalim Lab at Massachusetts General Hospital conducts translational research exploring protein and metabolite alterations that occur in uremia and can contribute to the adverse outcomes of kidney disease.